<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Psychopharmacology (Berl)</journal-id>
<journal-id journal-id-type="iso-abbrev">Psychopharmacology (Berl.)</journal-id>
<journal-title-group>
<journal-title>Psychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0033-3158</issn>
<issn pub-type="epub">1432-2072</issn>
<publisher>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<publisher-loc>Berlin/Heidelberg</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30267130</article-id>
<article-id pub-id-type="pmc">6267141</article-id>
<article-id pub-id-type="publisher-id">5045</article-id>
<article-id pub-id-type="doi">10.1007/s00213-018-5045-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Investigation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The 5-HT<sub>7</sub> receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT<sub>7</sub> receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sowa</surname>
<given-names>Joanna</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kusek</surname>
<given-names>Magdalena</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Siwiec</surname>
<given-names>Marcin</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sowa</surname>
<given-names>Joanna Ewa</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bobula</surname>
<given-names>Bartosz</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tokarski</surname>
<given-names>Krzysztof</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7579-3784</contrib-id>
<name>
<surname>Hess</surname>
<given-names>Grzegorz</given-names>
</name>
<address>
<email>grzegorz.hess@uj.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2227 8271</institution-id><institution-id institution-id-type="GRID">grid.418903.7</institution-id><institution>Department of Physiology, </institution><institution>Institute of Pharmacology, Polish Academy of Sciences, </institution></institution-wrap>Smetna 12, 31-343 Krakow, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>235</volume>
<issue>12</issue>
<fpage>3381</fpage>
<lpage>3390</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Rationale</title>
<p id="Par1">Chronic stress and corticosterone have been shown to affect serotonin (5-HT) neurotransmission; however, the influence of stress on the activity of the dorsal raphe nucleus (DRN), the main source of 5-HT in the forebrain, is not well understood. In particular, it is unknown if and how stress modifies DRN 5-HT<sub>7</sub> receptors, which are involved in the modulation of the firing of local inhibitory interneurons responsible for regulating the activity of DRN projection cells.</p>
</sec>
<sec>
<title>Objectives</title>
<p id="Par2">Our study aimed to investigate the effect of repeated corticosterone injections on the modulation of the inhibitory transmission within the DRN by 5-HT<sub>7</sub> receptors and whether it could be reversed by treatment with a 5-HT<sub>7</sub> receptor antagonist.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par3">Male Wistar rats received corticosterone injections repeated twice daily for 14 days. Spontaneous inhibitory postsynaptic currents (sIPSCs) were then recorded from DRN projection cells in ex vivo slice preparations obtained 24 h after the last injection.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par4">Repeated corticosterone administration resulted in decreased frequency, but not amplitude, of sIPSCs in DRN projection cells. There were no changes in the excitability of these cells; however, corticosterone treatment suppressed the 5-HT<sub>7</sub> receptor-mediated increase in sIPSC frequency. Administration of the 5-HT<sub>7</sub> receptor antagonist SB 269970 for 7 days beginning on the eighth day of corticosterone treatment reversed the detrimental effects of corticosterone on 5-HT<sub>7</sub> receptor reactivity and GABAergic transmission in the DRN.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par5">Elevated corticosterone level reduces DRN 5HT<sub>7</sub> receptor reactivity and decreases GABAergic transmission within the DRN, which can be reversed by the 5-HT<sub>7</sub> receptor antagonist SB 269970.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>5-HT<sub>7</sub> receptor</kwd>
<kwd>SB 269970</kwd>
<kwd>Stress</kwd>
<kwd>Corticosterone</kwd>
<kwd>Dorsal raphe nuclei</kwd>
<kwd>GABAergic transmission</kwd>
<kwd>Serotonin</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>National Science Center, Poland</institution>
</funding-source>
<award-id>DEC-2013/11/B/NZ4/04743</award-id>
<principal-award-recipient>
<name>
<surname>Hess</surname>
<given-names>Grzegorz</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer-Verlag GmbH Germany, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par6">Chronic stress and elevated blood cortisol levels are risk factors causally related to the development of a number of human pathologies including depressive disorders (reviewed in: Claes <xref ref-type="bibr" rid="CR12">2004</xref>; Parker et al. <xref ref-type="bibr" rid="CR38">2003</xref>; Reagan et al. <xref ref-type="bibr" rid="CR40">2008</xref>). It has been established that the pathomechanism of depressive disorders involves dysfunctions of the brain serotonin (5-hydroxytryptamine, 5-HT) system (reviewed in: Stahl <xref ref-type="bibr" rid="CR45">1998</xref>; Köhler et al. <xref ref-type="bibr" rid="CR25">2016</xref>). Animal studies have shown that both acute and chronic stressors affect 5-HT neurotransmission, evoking alterations in 5-HT release and reuptake as well as changes in extracellular 5-HT and 5-HT receptors’ levels (Adell et al. <xref ref-type="bibr" rid="CR1">1988</xref>; reviewed in: Chaouloff <xref ref-type="bibr" rid="CR10">2000</xref>).</p>
<p id="Par7">The dorsal raphe nucleus (DRN) is the main source of widespread 5-HT innervation, which modulates the activity of neuronal networks in target forebrain structures via several 5-HT receptor subtypes (reviewed in: Jacobs and Azmitia <xref ref-type="bibr" rid="CR23">1992</xref>; Celada et al. <xref ref-type="bibr" rid="CR8">2013</xref>). 5-HT may also influence the activity of DRN 5-HT neurons themselves as these cells express 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, and possibly 5-HT<sub>2</sub> autoreceptors (McDevitt and Neumaier <xref ref-type="bibr" rid="CR34">2011</xref>). 5-HT neurons of the DRN are known to express glucocorticoid receptors (GRs; Harfstrand et al. <xref ref-type="bibr" rid="CR21">1986</xref>). Chronic exposure to elevated corticosterone levels and uncontrollable stress have been demonstrated to induce a functional desensitization of 5-HT<sub>1A</sub> somatodendritic autoreceptors (Fairchild et al. <xref ref-type="bibr" rid="CR16">2003</xref>; Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>; Rozeske et al. <xref ref-type="bibr" rid="CR42">2011</xref>; reviewed in: McDevitt and Neumaier <xref ref-type="bibr" rid="CR34">2011</xref>), which normally effectively attenuate spiking activity of DRN 5-HT projection neurons (Aghajanian et al. <xref ref-type="bibr" rid="CR2">1990</xref>). Apart from 5-HT projections cells, the DRN contains a population of GABAergic interneurons which provide inhibitory input onto DRN projection cells. These inhibitory interneurons express 5-HT<sub>2A/C</sub> and possibly 5-HT<sub>1A</sub> and 5-HT<sub>6</sub> receptors (Asaoka et al. <xref ref-type="bibr" rid="CR4">2015</xref>; Gocho et al. <xref ref-type="bibr" rid="CR19">2013</xref>; Liu et al. <xref ref-type="bibr" rid="CR31">2000</xref>). Another serotonin receptor abundant in the DRN is the 5-HT<sub>7</sub> receptor (Roberts et al. <xref ref-type="bibr" rid="CR41">2004</xref>). Its role in the regulation of the activity of DRN neuronal network in normal and pathological conditions is not completely understood. Importantly, 5-HT<sub>7</sub> receptors in the DRN are present on GABAergic interneurons, but not on 5-HT cells (Monti et al. <xref ref-type="bibr" rid="CR36">2008</xref>; Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). 5-HT<sub>7</sub> receptor activation increases the mean frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from DRN projection cells, as well as induces their hyperpolarization and decreases their firing frequency (Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). Systemic blockade of 5-HT<sub>7</sub> receptors enhances 5-HT transmission and metabolism in target structures (Mnie-Filali et al. <xref ref-type="bibr" rid="CR35">2011</xref>; Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). While modifications of the GABAergic input onto DRN 5-HT neurons have been shown to play an important role in facilitating certain stress-induced behaviors (Challis et al. <xref ref-type="bibr" rid="CR9">2013</xref>; Crawford et al. <xref ref-type="bibr" rid="CR13">2013</xref>), the influence of prolonged elevation of corticosterone level on GABAergic transmission within the DRN and its modulation by the 5-HT<sub>7</sub> receptor has not yet been investigated. Repeated corticosterone administration has been proposed as a preclinical rat model to study links between stress, glucocorticoids, and depressive behavior (reviewed in: Sterner and Kalynchuk <xref ref-type="bibr" rid="CR46">2010</xref>). In the present study, we aimed at determining the effects of corticosterone treatment lasting 14 days on the ability of the 5-HT<sub>7</sub> receptor to modulate inhibitory transmission in the DRN.</p>
<p id="Par8">5-HT<sub>7</sub> receptor blockade has been shown to induce antidepressant-like effects in animal models (reviewed in: Ciranna and Catania <xref ref-type="bibr" rid="CR11">2014</xref>; Nikiforuk <xref ref-type="bibr" rid="CR37">2015</xref>). These effects occur faster than those induced by conventional antidepressant drugs (Mnie-Filali et al. <xref ref-type="bibr" rid="CR35">2011</xref>; reviewed in: Tokarski et al. <xref ref-type="bibr" rid="CR51">2012a</xref>). We have previously demonstrated that treatment with the selective 5-HT<sub>7</sub> receptor antagonist SB 269970 counteracted repeated restraint stress-induced modifications of glutamatergic transmission and synaptic plasticity in the rat frontal cortex (Tokarski et al. <xref ref-type="bibr" rid="CR50">2011</xref>). However, the plausible influence of 5-HT<sub>7</sub> receptor antagonism on the effects of prolonged corticosterone treatment on functional properties of DRN neurons has not yet been investigated. Therefore, the second aim of the present study was to determine whether blocking 5-HT<sub>7</sub> receptors with SB 269970 could reverse corticosterone-induced alterations in 5-HT<sub>7</sub> receptor-dependent modulation of GABAergic transmission in the DRN.</p>
</sec>
<sec id="Sec2">
<title>Experimental procedures</title>
<sec id="Sec3">
<title>Animals</title>
<p id="Par9">The experimental procedures were approved by the Local Ethics Committee for Animal Experiments at the Institute of Pharmacology, Polish Academy of Sciences, and were carried out in accordance with the European Community guidelines for the use of experimental animals and the national law. Male Wistar rats (Charles River, Germany) weighing approx. 150 g at the beginning of the experiment were housed in standard laboratory cages and maintained on a 12-h light/dark schedule (lights on at 07:00 and off at 19:00) with free access to standard food and tap water.</p>
</sec>
<sec id="Sec4">
<title>Treatment</title>
<p id="Par10">The animals were assigned to four groups. In the first experimental group (termed: Cort + SB), animals received corticosterone injections subcutaneously (dose 10 mg/kg, volume 1 ml/kg; in 1% solution of Tween 80 in water; Zahorodna and Hess <xref ref-type="bibr" rid="CR54">2006</xref>) twice daily for 14 days and, beginning on the eighth day of corticosterone treatment, additionally the 5-HT<sub>7</sub> receptor antagonist, SB 269970 (Tocris) for 7 days. SB 269970 was dissolved in 0.9% NaCl and injected intraperitoneally (dose 2.5 mg/kg, volume 1 ml/kg) once daily. The second group (termed: Cort + NaCl) received corticosterone for 14 days and, beginning on the eighth day of corticosterone treatment, injections of 0.9% NaCl for 7 days. Control rats for these treatments received 1% Tween 80 for 14 days and SB 269970 for 7 days (termed: Tween + SB) or 1% Tween 80 for 14 days and 0.9% NaCl for 7 days (termed: Tween + NaCl). The number of animals in each group was 10.</p>
</sec>
<sec id="Sec5">
<title>Slice preparation and incubation</title>
<p id="Par11">Brain slices were prepared 24 h after the last substance administration to avoid acute effects of corticosterone and SB 269970 (Hagan et al. <xref ref-type="bibr" rid="CR20">2000</xref>; Droste et al. <xref ref-type="bibr" rid="CR15">2008</xref>). Rats were anesthetized with isoflurane (Aerrane, Baxter, UK) and decapitated. Their brains were quickly removed and immersed in an ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM) NaCl (130), KCl (5), CaCl<sub>2</sub> (2.5), MgSO<sub>4</sub> (1.3), KH<sub>2</sub>PO<sub>4</sub> (1.25), NaHCO<sub>3</sub> (26), and <sc>d</sc>-glucose (10), bubbled with a mixture of 95% O<sub>2</sub>–5% CO<sub>2</sub>. Coronal midbrain slices containing the DRN (thickness 300 μm) were cut using a vibrating microtome (Leica VT1000) and subsequently stored submerged in ACSF at 30 ± 0.5 °C. Two or three slices were obtained from each animal.</p>
</sec>
<sec id="Sec6">
<title>Whole-cell recording</title>
<p id="Par12">After at least 3 h of preincubation, an individual slice was placed in the recording chamber and superfused without recycling at 2.5 ml/min with warm (32 ± 0.5 °C; Bacon and Beck <xref ref-type="bibr" rid="CR5">2000</xref>, Liu et al. <xref ref-type="bibr" rid="CR31">2000</xref>), modified ACSF of the following composition (in mM): NaCl (132), KCl (2), CaCl<sub>2</sub> (2.5), MgSO<sub>4</sub> (1.3), KH<sub>2</sub>PO<sub>4</sub> (1.25), NaHCO<sub>3</sub> (26), and <sc>d</sc>-glucose (10), bubbled with 95% O<sub>2</sub>–5% CO<sub>2</sub>. Modified ACSF also contained <italic>N</italic>-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-<italic>N</italic>-2-pyridinylcyclohexanecarboxamide (WAY 100635, Tocris, 2 μM<bold>)</bold> to block 5-HT<sub>1A</sub> receptors, as during the recordings, 5-carboxyamidotryptamine (5-CT, Tocris; 250 nM), a nonselective 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> receptor agonist, was used to activate 5-HT<sub>7</sub> receptors.</p>
<p id="Par13">Whole-cell recordings were obtained from the dorsal part of the midline region of the DRN. Neurons were visualized using the Zeiss Axioscope 2 upright microscope (Nomarski optics), a × 40 water immersion objective and an infrared camera. Recording pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus), using the Sutter Instrument P97 puller. The pipette solution contained (in mM) K-gluconate (130), NaCl (5), CaCl<sub>2</sub> (0.3), MgCl<sub>2</sub> (2), HEPES (10), Na<sub>2</sub>-ATP (5), Na-GTP (0.4), and EGTA (1). Osmolarity and pH were adjusted to 290 mOsm and 7.2, respectively. Pipettes had an open tip resistance of approx. 6 MΩ. Signals were recorded using the SEC 05LX amplifier (NPI, Germany), filtered at 2 kHz and digitized at 20 kHz using a Digidata 1440A interface and Clampex 10 software (Molecular Devices, USA).</p>
<p id="Par14">Putative 5-HT DRN projection neurons were identified by their response to hyper- and depolarizing current pulses (duration 400 ms; Galindo-Charles et al. <xref ref-type="bibr" rid="CR17">2008</xref>; Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). For each cell, the relationship between the injected current intensity and the number of spikes was plotted and gain was determined as the slope of a straight line fitted to experimental data.</p>
<p id="Par15">Cells were voltage-clamped at 0 mV, and after 15 min of stabilization sIPSCs were recorded for 4 min as outwards currents. We have previously shown that these currents could be blocked by bicuculline (Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). Next, 5-carboxyamidotryptamine (5-CT, Tocris; 250 nM) was added to the ACSF (Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). Following 15 min of stabilization, sIPSCs were again recorded for 4 min. Data were accepted for analysis when the access resistance ranged between 15 and 18 MΩ and remained stable (&lt; 25% change) during the recording.</p>
<p id="Par16">Spontaneous IPSCs were detected offline using Mini Analysis software (Synaptosoft), and individual synaptic events were manually selected for further analysis. The threshold amplitude for the detection of an IPSC was set to 10 pA. IPSC kinetics were determined from the averaged IPSC for each cell. Rise time was measured as the time needed for the current to rise from 10 to 90% of the peak. The decay time constant (tau) was determined from fitting an exponential function to the decay phase of the IPSC.</p>
</sec>
<sec id="Sec7">
<title>Statistical analysis</title>
<p id="Par17">Rats were weighed on a daily basis. Average growth curves for each experimental treatment group were constructed by fitting linear regression lines to raw data. Slopes for the individual fits were compared across groups using the two-way analysis of variance (ANOVA), followed by Sidak’s multiple comparisons test. Statistical analyses of the electrophysiological data were carried out using two-way ANOVA followed by Sidak’s multiple comparison test. For estimating the effects of 5-CT on synaptic activity in brain slices from the different treatment groups, the percentage change relative to baseline was used as the dependent variable. The analysis was performed in GraphPad Prism 7 software. The results are expressed as the mean ± SEM. The significance level was set at <italic>p</italic> = 0.05 for all comparisons.</p>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<sec id="Sec9">
<title>SB 269970 does not change the effect of corticosterone on animal body weight</title>
<p id="Par18">Rats from the Cort + NaCl group gained significantly less weight compared to the animals receiving the vehicle (Tween + NaCl group; Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Concurrent administration of SB 269970 and corticosterone (Cort + SB group) did not modify the effect of corticosterone on body weight gain (measured as the slope of the linear regression line). No differences were evident between rats receiving the vehicle and SB 269970 injections (Tween + SB group) and the Tween + NaCl group. A significant main effect of corticosterone on body weight gain (<italic>F</italic><sub>(1, 36)</sub> = 147.1, <italic>p</italic> &lt; 0.0001) was observed. Animals from the Cort + NaCl and Cort + SB groups gained weight significantly slower than Tween + NaCl receiving rats (<italic>p</italic> &lt; 0.0001, Sidak’s multiple comparisons test).<fig id="Fig1"><label>Fig. 1</label><caption><p>Effects of repeated corticosterone and 5-HT<sub>7</sub> receptor antagonist SB 269970 injections on animal body weight. Rats from the Cort + NaCl group, as well as from the Cort + SB group, gained significantly less weight compared to control (Tween + NaCl) animals. Concurrent administration of SB 269970 and corticosterone (Cort + SB) did not modify the effect of corticosterone on body weight gain (measured as the slope of the linear regression line). No differences were evident between the Tween + SB and the Tween + NaCl group. The number of animals in each group was 10. Data are mean ± SEM. ***<italic>p</italic> &lt; 0.001. The arrow indicates the first day of SB 269970 injections</p></caption><graphic id="MO1" xlink:href="213_2018_5045_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec10">
<title>Lack of effect of corticosterone and SB 269970, alone and in combination, on DRN neuronal excitability</title>
<p id="Par19">All cells subjected to analysis, when stimulated by depolarizing current pulses fired broad action potentials with a “notch” on their descending phase (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), characteristic of putative 5-HT projection neurons (see also: Galindo-Charles et al. <xref ref-type="bibr" rid="CR17">2008</xref>; Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>). The resting membrane potential and input resistance of recorded DRN neurons did not differ significantly between groups (Table <xref ref-type="table" rid="Tab1">1</xref>). In addition, there were no differences in neuronal excitability between any groups.<fig id="Fig2"><label>Fig. 2</label><caption><p>Repeated corticosterone and SB 269970 injections do not influence basic electrophysiological properties and excitability of DRN projection neurons. <bold>a</bold> Examples of single action potentials from all examined groups, with the “notch” on their descending phase marked with an asterisk. <bold>b</bold> Responses of representative projection neuron to different current injections (step: 20 pA) recorded in DRN slice prepared from control (Tween + NaCl) animal. <bold>c</bold> Relationship between spiking rate and injected current for the cell shown in panel <bold>b</bold>. The slope of the straight line fitted to experimental data represents gain. <bold>d</bold> Summary graph showing the mean gain (± SEM) of all neurons from the Tween + NaCl, Tween + SB, Cort + NaCl, and Cort + SB-treated rats. The differences between groups are not significant</p></caption><graphic id="MO2" xlink:href="213_2018_5045_Fig2_HTML"></graphic></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Effects of the treatments on basic electrophysiological characteristics of recorded neurons (mean ± SEM)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th><italic>V</italic><sub>m</sub> (mV)</th><th><italic>R</italic><sub>m</sub> (MΩ)</th><th>Gain (Hz/pA)</th><th>
<italic>n</italic>
</th></tr></thead><tbody><tr><td>Tween + NaCl</td><td>− 67.86 ± 1.34</td><td>593.70 ± 29.12</td><td>0.035 ± 0.003</td><td>14</td></tr><tr><td>Tween + SB</td><td>− 67.60 ± 0.88</td><td>578.70 ± 18.24</td><td>0.035 ± 0.001</td><td>15</td></tr><tr><td>Cort + NaCl</td><td>− 69.00 ± 1.14</td><td>591.70 ± 17.96</td><td>0.034 ± 0.003</td><td>17</td></tr><tr><td>Cort + SB</td><td>− 64.78 ± 1.30</td><td>592.80 ± 18.61</td><td>0.034 ± 0.002</td><td>18</td></tr></tbody></table><table-wrap-foot><p>Differences between values are not significant (<italic>p</italic> &gt; 0.05)</p><p><italic>V</italic><sub>m</sub> resting membrane potential, <italic>R</italic><sub>m</sub> input resistance, <italic>n</italic> number of cells</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec11">
<title>SB 269970 reverses effects of corticosterone treatment on the inhibitory input to DRN neurons</title>
<p id="Par20">There was a significant effect of corticosterone treatment (<italic>F</italic><sub>(1, 60)</sub> = 14.66, <italic>p</italic> = 0.0003), SB 269970 treatment (<italic>F</italic><sub>(1, 60)</sub> = 15.31, <italic>p</italic> = 0.0002), and their interaction (<italic>F</italic><sub>(1, 60)</sub> = 14.99, <italic>p</italic> = 0.0003) on the frequency of sIPSCs. The sIPSC frequency was lower in the group receiving corticosterone and 0.9% NaCl injections (Cort + NaCl) compared to the Tween + NaCl group (0.27 ± 0.02 Hz vs. 0.82 ± 0.08 Hz, respectively; <italic>n</italic> = 17 and 14, <italic>t</italic> = 5.361, <italic>df</italic> = 60, <italic>p</italic> &lt; 0.0001; Sidak’s multiple comparison test), as well as when compared to the Cort + SB group (0.27 ± 0.02 Hz vs. 0.83 ± 0.06 Hz, respectively; <italic>n</italic> = 17 and 18, <italic>t</italic> = 5.783, <italic>df</italic> = 60, <italic>p</italic> &lt; 0.0001; Sidak’s multiple comparison test; Fig. <xref ref-type="fig" rid="Fig3">3</xref>b<sub>1</sub>, c<sub>1</sub>). No differences between the Cort + SB and Tween + NaCl groups were observed (0.83 ± 0.06 vs. 0.82 ± 0.08, respectively; <italic>n</italic> = 18 and 14, <italic>t</italic> = 0.059, <italic>df</italic> = 60, <italic>p</italic> = 0.9999; Sidak’s multiple comparison test). There were no significant effects of SB 269970 injections (Tween + SB) on sIPSC frequency compared to control (Tween + NaCl) (0.82 ± 0.10 vs. 0.82 ± 0.08, respectively; <italic>n</italic> = 15 and 14, <italic>t</italic> = 0.028, <italic>df</italic> = 60, <italic>p</italic> = 0.9999; Sidak’s multiple comparison test).<fig id="Fig3"><label>Fig. 3</label><caption><p>SB 269970 reverses the effect of repeated corticosterone administration on DRN GABAergic transmission. <bold>a</bold> Sample recordings from representative neurons in slices prepared from animals treated with Tween + NaCl (<italic>first trace</italic>), Tween + SB (<italic>second trace</italic>), Cort + NaCl (<italic>third trace</italic>), and Cort + SB (<italic>fourth trace</italic>). Dots mark spontaneous synaptic events. (<bold>b</bold><sub><bold>1</bold></sub>) Cumulative probability plots of inter-event intervals of sIPSCs recorded from individual representative neurons from all four groups of rats. <bold>b</bold><sub><bold>2</bold></sub> Cumulative probability plots of amplitudes of sIPSCs recorded from individual representative neurons. <bold>c</bold><sub><bold>1</bold></sub> Summary graph showing the mean frequency (± SEM) of sIPSCs recorded from all neurons from the Tween + NaCl, Tween + SB, Cort + NaCl, and Cort + SB-treated rats. ***<italic>p</italic> &lt; 0.001. <bold>c</bold><sub><bold>2</bold></sub> A comparison of the mean amplitude (± SEM) of sIPSCs recorded from all neurons of the four investigated groups of animals. Labels as in panel <bold>c</bold><sub><bold>1</bold></sub></p></caption><graphic id="MO3" xlink:href="213_2018_5045_Fig3_HTML"></graphic></fig></p>
<p id="Par21">The analysis did not reveal any effect of treatments (corticosterone treatment: <italic>F</italic>(<sub>1, 60)</sub> = 0.8172, <italic>p</italic> = 0.3696; SB 269970 treatment: <italic>F</italic><sub>(1, 60)</sub> = 1.851, <italic>p</italic> = 0.1787) or their interaction (<italic>F</italic><sub>(1, 60)</sub> = 0.2929, <italic>p</italic> = 0.5903) on sIPSC amplitude (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b<sub>2</sub>, c<sub>2</sub>).</p>
<p id="Par22">No significant effect of SB 269970 treatment (<italic>F</italic><sub>(1, 60)</sub> = 0.4056, <italic>p</italic> = 0.5266) and interaction (<italic>F</italic><sub>(1, 60)</sub> = 0.1992, <italic>p</italic> = 0.6569), but significant effect of corticosterone treatment (<italic>F</italic><sub>(1, 60)</sub> = 6.739, <italic>p</italic> = 0.0118) on the rise time of sIPSCs was observed. However, multiple comparisons with Sidak’s test did not reveal any significant differences between groups. A significant effect of treatment with SB 269970 (<italic>F</italic><sub>(1, 60)</sub> = 5.292, <italic>p</italic> = 0.0249) on the decay time constant of sIPSCs and interaction (<italic>F</italic><sub>(1, 60)</sub> = 3.877, <italic>p</italic> = 0.0536) with no effect of corticosterone treatment (<italic>F</italic><sub>(1, 60)</sub> = 1.929, <italic>p</italic> = 0.1700) was observed (Table <xref ref-type="table" rid="Tab2">2</xref>). The decay time constant was found to be shorter in the group of animals receiving Tween and SB 269970 injections compared to control (6.58 ± 0.19 vs. 7.46 ± 0.17, respectively; <italic>n</italic> = 15 and 14, <italic>t</italic> = 2.886, <italic>df</italic> = 60, <italic>p</italic> = 0.032; Sidak’s multiple comparison test).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Effects of corticosterone and SB 269970 treatment on sIPSC characteristics (mean ± SEM) in the four tested groups of animals</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Mean frequency (Hz)</th><th>Mean amplitude (pA)</th><th>Rise time (ms)</th><th>Decay time constant (<italic>τ</italic>, ms)</th><th>
<italic>n</italic>
</th></tr></thead><tbody><tr><td>Tween + NaCl</td><td>0.82 ± 0.08</td><td>20.02 ± 0.63</td><td>1.75 ± 0.11</td><td>7.46 ± 0.17</td><td>14</td></tr><tr><td>Tween + SB</td><td>0.83 ± 0.10</td><td>19.46 ± 0.69</td><td>1.74 ± 0.08</td><td>6.58 ± 0.19 *</td><td>15</td></tr><tr><td>Cort + NaCl</td><td>0.27 ± 0.02***</td><td>21.00 ± 0.62</td><td>2.00 ± 0.07</td><td>7.34 ± 0.21</td><td>17</td></tr><tr><td>Cort + SB</td><td>0.83 ± 0.06</td><td>19.71 ± 0.72</td><td>1.91 ± 0.07</td><td>7.27 ± 0.22</td><td>18</td></tr></tbody></table><table-wrap-foot><p><italic>n</italic> number of cells</p><p>*<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001; Sidak’s multiple comparison test</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec12">
<title>Changes in 5-HT<sub>7</sub> receptor function induced by corticosterone treatment are reversed by SB 269970</title>
<p id="Par23">A two-way ANOVA revealed a significant interaction between corticosterone and SB 269970 treatments on the 5-CT-induced percentage change in sIPSC frequency (<italic>F</italic><sub>(1,60)</sub> = 8.767, <italic>p</italic> = 0.0044). This was not accompanied by significant main effects of either corticosterone treatment (<italic>F</italic><sub>(1,60)</sub> = 2.966, <italic>p</italic> = 0.0902) or SB 269970 treatment (<italic>F</italic><sub>(1,60)</sub> = 3.329, <italic>p</italic> = 0.0731). The 5-CT-induced increase in sIPSC frequency was similar in the Tween + NaCl and Tween + SB groups (114.14 ± 3.14%, <italic>n</italic> = 14, vs. 116.65 ± 6.66%, <italic>n</italic> = 15 respectively, adjusted <italic>p</italic> = 0.9709, post hoc Sidak’s multiple comparisons test). Corticosterone abolished the 5-HT<sub>7</sub> effect as there was no 5-CT-mediated increase in sIPSC frequency in the Cort + NaCl group when compared to the Tween + NaCl group (97.49 ± 4.03%, <italic>n</italic> = 17, vs. 114.14 ± 3.14%, <italic>n</italic> = 14 respectively, adjusted <italic>p</italic> = 0.0110, post hoc Sidak’s multiple comparisons test). Co-administration of corticosterone and SB 269970 fully rescued the effect of 5-CT on sIPSC frequency, back to the level seen in the Tween + NaCl group (116.10 ± 3.91%, <italic>n</italic> = 18, vs. 114.14 ± 3.14%, <italic>n</italic> = 14, respectively, adjusted <italic>p</italic> &gt; 0.9999, post hoc Sidak’s multiple comparisons test) (Fig. <xref ref-type="fig" rid="Fig4">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>SB 269970 reverses the effect of repeated corticosterone administration on 5-HT<sub>7</sub> receptor reactivity in the DRN. <bold>a</bold><sub><bold>1</bold></sub> Sample recordings from a representative neuron in slice prepared from the rat receiving Tween + NaCl before (<italic>upper trace</italic>) and after addition of 250 nM 5-CT to the ACSF (<italic>lower trace</italic>). <bold>a</bold><sub><bold>2</bold></sub> Sample recordings from a representative neuron in slice prepared from the animal receiving Cort + NaCl before (<italic>upper trace</italic>) and after addition of 250 nM 5-CT to the ACSF (<italic>lower trace)</italic>. Gray dots mark spontaneous synaptic events accepted for analysis. <bold>b</bold> The effect of 5-HT<sub>7</sub> receptor activation on the sIPSC frequency (mean ± SEM) shown as a percentage of basal sIPSC frequency (before 5-CT addition); *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; <italic>ns</italic> non-significant effect</p></caption><graphic id="MO4" xlink:href="213_2018_5045_Fig4_HTML"></graphic></fig></p>
<p id="Par24">There were no significant effects of corticosterone treatment, SB 269970 treatment, or their interaction on 5-CT-induced percentage changes in sIPSC amplitude (main effect of corticosterone treatment: <italic>F</italic>(1, 60) = 0.3492, <italic>p</italic> = 0.8524; main effect of SB 269970 treatment: <italic>F</italic>(1, 60) = 0.5211, <italic>p</italic> = 0.4732; interaction: <italic>F</italic>(1, 60) = 0.1256, <italic>p</italic> = 0.7243), sIPSC rise time (main effect of corticosterone treatment: <italic>F</italic>(1, 60) = 0.1341, <italic>p</italic> = 0.7155; main effect of SB 269970 treatment: <italic>F</italic>(1, 60) = 0.5632, <italic>p</italic> = 0.4559; interaction: <italic>F</italic>(1, 60) = 3.2700, <italic>p</italic> = 0.0756), and sIPSC decay time constant (main effect of corticosterone treatment: <italic>F</italic>(1, 60) = 0.3060, <italic>p</italic> = 0.5822, main effect of SB 269970 treatment: <italic>F</italic>(1, 60) = 0.5458, <italic>p</italic> = 0.4629; interaction: <italic>F</italic>(1, 60) = 1.9230, <italic>p</italic> = 0.1706).</p>
</sec>
</sec>
<sec id="Sec13">
<title>Discussion</title>
<p id="Par25">The results of the present study demonstrate that corticosterone treatment lasting 14 days induced a decrease in the frequency of sIPSCs recorded from DRN projection neurons without significant changes in the mean amplitude and kinetic properties, apart from a small decrease in the decay time constant in the case of sIPSCs in cells from the Tween + SB group of animals. These observations are suggestive of a presynaptic location of corticosterone-induced effects on GABAergic transmission within the DRN. In line with this finding, a moderate, chronic increase in circulating corticosterone level has been shown to exert no significant effect on the response of rat DRN 5-HTergic cells to either GABA<sub>A</sub> or GABA<sub>B</sub> receptor activation (Judge et al. <xref ref-type="bibr" rid="CR24">2004</xref>). In the ventromedial DRN of stressed mice subjected to 5-day social defeat, a decrease in the frequency and a smaller decrease in the amplitude of sIPSCs have been observed (Crawford et al. <xref ref-type="bibr" rid="CR13">2013</xref>). It is thus likely that repeated administration of corticosterone brought about a decrease in neurotransmitter release from GABAergic terminals due to a decrease in spiking activity of DRN GABAergic interneurons. It should also be noted that since the DRN receives GABAergic inputs from extrinsic sources including the hypothalamus, substantia nigra, ventral tegmental area, and rostromedial tegmental nucleus (reviewed in: Soiza-Reilly and Commons <xref ref-type="bibr" rid="CR44">2014</xref>), it is conceivable that systemic administration of corticosterone reduced the activity of these inhibitory afferent projections as well.</p>
<p id="Par26">Obtained results demonstrate that repeated corticosterone administration suppressed the reactivity of 5-HT<sub>7</sub> receptors in the DRN. These receptors appear to be located on DRN GABA interneurons, but not projection neurons, and their activation has earlier been shown to increase the frequency of sIPSCs recorded from DRN 5-HT projection neurons (Mnie-Filali et al. <xref ref-type="bibr" rid="CR35">2011</xref>; Kusek et al. <xref ref-type="bibr" rid="CR26">2015</xref>), consistent with the fact that 5-HT<sub>7</sub> receptors’ agonists raise the excitability of the neuron that expresses these receptors (Bacon and Beck <xref ref-type="bibr" rid="CR5">2000</xref>; Bickmeyer et al. <xref ref-type="bibr" rid="CR7">2002</xref>; Tokarski et al. <xref ref-type="bibr" rid="CR48">2003</xref>). Thus, another consequence of prolonged corticosterone exposure is a lack of 5-HT<sub>7</sub> receptor-mediated indirect inhibitory effect on DRN projection cells. It is tempting to speculate that observed suppression of the reactivity of DRN 5-HT<sub>7</sub> receptors resulted from enhanced 5-HT release within the DRN. It has been reported that treatment with corticosterone does not result in changes in the basal firing rate of DRN 5-HT neurons or the basal extracellular level of 5-HT in the DRN (Leitch et al. <xref ref-type="bibr" rid="CR30">2003</xref>; Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>). However, GR-mediated reduction of the autoinhibitory function of 5-HT<sub>1A</sub> somatodendritic receptors in DRN 5-HT neurons has been found to occur after short- and long-term (4–7 weeks) treatment with corticosterone (Fairchild et al. <xref ref-type="bibr" rid="CR16">2003</xref>; Laaris et al. <xref ref-type="bibr" rid="CR27">1995</xref>; Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>). Thus, the enhanced 5-HT release is likely to occur in the DRN of corticosterone-treated animals when excitatory inputs to the DRN (reviewed in: Lee et al. <xref ref-type="bibr" rid="CR29">2003</xref>) are active. Larger surges of 5-HT within the DRN would result in a stronger, than normal, activation of 5-HT receptors expressed by local neurons, which might lead to their desensitization and/or downregulation. Experiments in vitro have demonstrated that agonist treatment results in a downregulation of 5-HT<sub>7</sub> receptors in hippocampal neuronal cultures (Vasefi et al. <xref ref-type="bibr" rid="CR53">2013</xref>) and desensitization of these receptors in astrocytes of the rat frontal cortex (Shimizu et al. <xref ref-type="bibr" rid="CR43">1998</xref>). It should also be noted that 5-HT<sub>7</sub> receptor functional desensitization is likely to contribute to a decrease in spiking activity of DRN GABAergic interneurons and observed reduction in sIPSCs frequency in DRN projection neurons of corticosterone-treated rats.</p>
<p id="Par27">It is also conceivable that GR activation might influence the expression level of 5-HT<sub>7</sub> receptors, as is the case with 5-HT<sub>1A</sub> receptor in the DRN (Laaris et al. <xref ref-type="bibr" rid="CR27">1995</xref>); however, to the best of our knowledge, no data are available on the effects of elevated blood plasma corticosterone on the expression of 5-HT<sub>7</sub> receptors in the DRN. While adrenalectomy results in an increase of 5-HT<sub>7</sub> receptor mRNA expression in the hippocampus (Le Corre et al. <xref ref-type="bibr" rid="CR28">1997</xref>), we have previously found that repeated administration of corticosterone for 21 days changed neither the affinity (<italic>K</italic><sub>d</sub>) of hippocampal 5-HT<sub>7</sub> receptors to [<sup>3</sup>H]-SB 269970 nor their maximum density (<italic>B</italic><sub>max</sub>, Tokarski et al. <xref ref-type="bibr" rid="CR49">2009</xref>).</p>
<p id="Par28">The present data demonstrate that administration of SB 269970, repeated for 7 days, normalized the frequency of sIPSCs in DRN projection cells of corticosterone-treated rats and restored the reactivity of 5-HT<sub>7</sub> receptors in the DRN. It has been shown that SB 269970 rapidly enters the brain after intraperitoneal administration and is eliminated within less than 2 h (Hagan et al. <xref ref-type="bibr" rid="CR20">2000</xref>). Thus, in our experiments, the blockade of 5-HT<sub>7</sub> receptors largely coincided with a rapid rise in corticosterone level in the brain which normalizes within 2 h after its subcutaneous administration (Droste et al. <xref ref-type="bibr" rid="CR15">2008</xref>). If observed suppression of the reactivity of 5-HT<sub>7</sub> receptors in DRN GABA interneurons indeed resulted from corticosterone-induced enhancement of 5-HT release within DRN and excessive activation of 5-HT<sub>7</sub> receptors, their temporal blockade might prevent the occurrence of this effect and lead to the restoration of their reactivity. Interestingly, chronic restraint stress-related hyperactivity of the hypothalamic-pituitary-adrenal axis of rats has recently been linked to an increased expression of 5-HT<sub>7</sub> receptors in the adrenal cortex (reviewed in: Terrón <xref ref-type="bibr" rid="CR47">2014</xref>). It has been reported that SB-656104 (another 5-HT<sub>7</sub> receptor antagonist) significantly inhibited the sensitized corticosterone response to acute restraint in chronically stressed animals (García-Iglesias et al. <xref ref-type="bibr" rid="CR18">2013</xref>). It is conceivable that similar mechanisms might be operable in our experimental model involving repeated corticosterone administration.</p>
<p id="Par29">Administration of SB 269970 alone, repeated for 7 days, affected neither sIPSCs frequency nor the reactivity of 5-HT<sub>7</sub> receptors in the DRN. It has been reported that 1-week long treatment of rats with the 5-HT<sub>7</sub> receptor antagonist SB 269970, in a dose comparable to the one used in the present study, did not alter the firing of DRN 5-HT cells but resulted in desensitization of somatodendritic 5-HT<sub>1A</sub> autoreceptors, thus providing a prospective fast-acting antidepressant strategy (Mnie-Filali et al. <xref ref-type="bibr" rid="CR35">2011</xref>). It should be noted that SB 269970 may differently influence the expression of 5-HT<sub>7</sub> receptors, as in vitro experiments demonstrated downregulation, upregulation, or lack of effect of SB 269970 on these receptors, depending on a particular splice variant (Andressen et al. <xref ref-type="bibr" rid="CR3">2015</xref>). We have demonstrated previously that treatment with SB 269970 induced functional desensitization of 5-HT<sub>7</sub> receptors in the rat hippocampus (Tokarski et al. <xref ref-type="bibr" rid="CR52">2012b</xref>). An earlier study has shown that corticosterone administration lasting 7–21 days enhanced the excitatory effect of 5-HT<sub>7</sub> receptor activation on the activity of hippocampal pyramidal neurons (Tokarski et al. <xref ref-type="bibr" rid="CR49">2009</xref>). Thus, the effects of prolonged corticosterone exposure on hippocampal (Tokarski et al. <xref ref-type="bibr" rid="CR49">2009</xref>, <xref ref-type="bibr" rid="CR52">2012b</xref>) and DRN (this study) 5-HT<sub>7</sub> receptors are opposite. However, the results of the present study complement previous work which demonstrated that treatment with SB 269970 counteracts repeated restraint stress-induced detrimental modifications of the glutamatergic transmission and synaptic plasticity in the rat frontal cortex (Tokarski et al. <xref ref-type="bibr" rid="CR50">2011</xref>).</p>
<p id="Par30">Repeated corticosterone administration, as a model of uncontrollable stress, has been suggested to represent a rodent model of depression and anxiety (Zhao et al. <xref ref-type="bibr" rid="CR55">2008</xref>; Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>). The amount of corticosterone administered and the duration of treatment, which produce a depressive-like phenotype, differ between laboratories (reviewed in: Sterner and Kalynchuk <xref ref-type="bibr" rid="CR46">2010</xref>). However, repeated corticosterone administration generally produces behavioral and neurobiological alterations that resemble the symptoms and neurobiological changes associated with human depression, including increases in passive behavior and decreases in active behaviors in the forced swim test, inhibited sexual behavior, decreased sucrose intake, decreased responding for food, and decreased grooming (reviewed in: Sterner and Kalynchuk <xref ref-type="bibr" rid="CR46">2010</xref>). Importantly, a decrease in 5-HT level by a half in rat frontal cortex has been reported after corticosterone administration in drinking water lasting for 8 weeks (Luine et al. <xref ref-type="bibr" rid="CR32">1993</xref>). It should be noted that no change in the basal firing rate of DRN projection cells or extracellular level of 5-HT in the DRN has been found to occur in mice after 7 weeks of corticosterone treatment (Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>), but this discrepancy might be attributed to species differences. A decreased activity of the serotonergic system has also been found to occur after chronic unpredictable stress, which induces depressive-like phenotype as well (Bambico et al. <xref ref-type="bibr" rid="CR6">2009</xref>, reviewed in: Mahar et al. <xref ref-type="bibr" rid="CR33">2014</xref>). On the other hand, after administration of corticosterone for 14 days, no change in basal extracellular 5-HT level has been observed in rat hippocampus (Leitch et al. <xref ref-type="bibr" rid="CR30">2003</xref>). After 12 days of corticosterone treatment, no change in 5-HT level but a significantly increased amount of 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA) in rat frontal cortex has been reported, indicative of an increased metabolism of 5-HT in the DRN target structure (Inoue and Koyama <xref ref-type="bibr" rid="CR22">1996</xref>). Thus, corticosterone-induced decrease in the activity of the rat serotonergic system appears to develop only after prolonged exposure to corticosterone, while the early effects may include an increased excitability of DRN projection neurons primarily due to a reduction in the autoinhibitory function of 5-HT<sub>1A</sub> somatodendritic receptors (Fairchild et al. <xref ref-type="bibr" rid="CR16">2003</xref>; Laaris et al. <xref ref-type="bibr" rid="CR27">1995</xref>; Rainer et al. <xref ref-type="bibr" rid="CR39">2012</xref>) and a reduced GABAergic input from local DRN interneurons (this study). These effects may be accompanied by an elevation of the expression of gene encoding tryptophan hydroxylase 2 (<italic>tph2</italic>), the rate-limiting enzyme for brain 5-HT synthesis in the DRN, reported to occur after 3 weeks of treatment of rats with corticosterone (Donner et al. <xref ref-type="bibr" rid="CR14">2012</xref>).</p>
</sec>
<sec id="Sec14">
<title>Conclusion</title>
<p id="Par31">In conclusion, the results of the present study indicate that repeated administration of exogenous corticosterone induces a reduction of 5-HT<sub>7</sub> receptor reactivity and weakening of inhibitory transmission within the DRN neuronal network. Administration of a 5-HT<sub>7</sub> receptor antagonist restores 5-HT<sub>7</sub> receptor reactivity and reverses the effects of elevated corticosterone levels on inhibitory transmission within the DRN. These findings may be of importance for the treatment of stress-related disorders.</p>
</sec>
</body>
<back>
<notes notes-type="funding-information">
<title>Funding information</title>
<p>This work is supported by the grant DEC-2013/11/B/NZ4/04743 financed by the National Science Center, Poland, and by statutory funds from the Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.</p>
</notes>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<p>The experimental procedures were approved by the Local Ethics Committee for Animal Experiments at the Institute of Pharmacology, Polish Academy of Sciences, and were carried out in accordance with the European Community guidelines for the use of experimental animals and the national law.</p>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garcia-Marquez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Armario</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gelpi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress</article-title>
<source/>J Neurochem
          <year>1988</year>
<volume>50</volume>
<fpage>1678</fpage>
<lpage>1681</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1988.tb02462.x</pub-id>
<pub-id pub-id-type="pmid">2453609</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aghajanian</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Sprouse</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Sheldon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms</article-title>
<source/>Ann N Y Acad Sci
          <year>1990</year>
<volume>600</volume>
<fpage>93</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.1990.tb16875.x</pub-id>
<pub-id pub-id-type="pmid">2123618</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andressen</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Manfra</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Brevik</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Ulsund</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Vanhoenacker</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>FO</given-names>
</name>
<name>
<surname>Krobert</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT<sub>7</sub> receptors</article-title>
<source/>Br J Pharmacol
          <year>2015</year>
<volume>172</volume>
<fpage>3846</fpage>
<lpage>3860</lpage>
<pub-id pub-id-type="doi">10.1111/bph.13169</pub-id>
<pub-id pub-id-type="pmid">25884989</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asaoka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nagayasu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishitani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yamashiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shirakawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT<sub>6</sub> receptors in the dorsal raphe nucleus</article-title>
<source/>Neuropharmacology
          <year>2015</year>
<volume>95</volume>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.03.032</pub-id>
<pub-id pub-id-type="pmid">25863120</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacon</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>5-Hydroxytryptamine7 receptor activation decreases slow after hyperpolarization amplitude in CA3 hippocampal pyramidal cells</article-title>
<source/>J Pharmacol Exp Ther
          <year>2000</year>
<volume>294</volume>
<fpage>672</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="pmid">10900247</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bambico</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Gobbi</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Decline in serotonergic firing activity and desensitization of 5-HT<sub>1A</sub> autoreceptors after chronic unpredictable stress</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2009</year>
<volume>19</volume>
<fpage>215</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2008.11.005</pub-id>
<pub-id pub-id-type="pmid">19147333</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bickmeyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Heine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manzke</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons</article-title>
<source/>Eur J Neurosci
          <year>2002</year>
<volume>16</volume>
<fpage>209</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.02072.x</pub-id>
<pub-id pub-id-type="pmid">12169103</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celada</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Puig</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Artigas</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Serotonin modulation of cortical neurons and networks</article-title>
<source/>Front Integr Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>25</fpage>
<pub-id pub-id-type="doi">10.3389/fnint.2013.00025</pub-id>
<pub-id pub-id-type="pmid">23626526</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Challis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boulden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Veerakumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Espallergues</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vassoler</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Berton</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<fpage>13978</fpage>
<lpage>13988</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.2383-13.2013</pub-id>
<pub-id pub-id-type="pmid">23986235</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaouloff</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Serotonin, stress and corticoids</article-title>
<source/>J Psychopharmacol
          <year>2000</year>
<volume>14</volume>
<fpage>139</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1177/026988110001400203</pub-id>
<pub-id pub-id-type="pmid">10890308</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciranna</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Catania</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>5-HT<sub>7</sub> receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders</article-title>
<source/>Front Cell Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>250</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00250</pub-id>
<pub-id pub-id-type="pmid">25221471</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claes</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>CRH, stress, and major depression: a psychobiological interplay</article-title>
<source/>Vitam Horm
          <year>2004</year>
<volume>69</volume>
<fpage>117</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/S0083-6729(04)69005-4</pub-id>
<pub-id pub-id-type="pmid">15196881</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crawford</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Social stress alters inhibitory synaptic input to distinct subpopulations of raphe serotonin neurons</article-title>
<source/>ACS Chem Neurosci
          <year>2013</year>
<volume>4</volume>
<fpage>200</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1021/cn300238j</pub-id>
<pub-id pub-id-type="pmid">23336059</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donner</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Lukkes</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lowry</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression</article-title>
<source/>Psychoneuroendocrinology
          <year>2012</year>
<volume>37</volume>
<issue>5</issue>
<fpage>645</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.08.008</pub-id>
<pub-id pub-id-type="pmid">21924839</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Droste</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>de Groote</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Lightman</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Reul</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Linthorst</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress</article-title>
<source/>Endocrinology
          <year>2008</year>
<volume>149</volume>
<fpage>3244</fpage>
<lpage>3253</lpage>
<pub-id pub-id-type="doi">10.1210/en.2008-0103</pub-id>
<pub-id pub-id-type="pmid">18356272</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fairchild</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leitch</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Acute and chronic effects of corticosterone on 5-HT<sub>1A</sub> receptor-mediated autoinhibition in the rat dorsal raphe nucleus</article-title>
<source/>Neuropharmacology
          <year>2003</year>
<volume>45</volume>
<fpage>925</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1016/S0028-3908(03)00269-7</pub-id>
<pub-id pub-id-type="pmid">14573385</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galindo-Charles</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hernandez-Lopez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Galarraga</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tapia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bargas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garduño</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frías-Dominguez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Drucker-Colin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mihailescu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors</article-title>
<source/>Synapse
          <year>2008</year>
<volume>62</volume>
<fpage>601</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1002/syn.20526</pub-id>
<pub-id pub-id-type="pmid">18512214</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-Iglesias</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Mendoza-Garrido</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gutiérrez-Ospina</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rangel-Barajas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Noyola-Díaz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Terrón</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT<sub>7</sub> receptors</article-title>
<source/>Neuropharmacology
          <year>2013</year>
<volume>71</volume>
<fpage>216</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.03.013</pub-id>
<pub-id pub-id-type="pmid">23542440</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gocho</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yanagawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saitow</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus</article-title>
<source/>J Physiol Sci
          <year>2013</year>
<volume>63</volume>
<fpage>147</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1007/s12576-012-0250-7</pub-id>
<pub-id pub-id-type="pmid">23275149</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagan</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Jeffrey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Deeks</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Stean</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Piper</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Upton</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Medhurst</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Middlemiss</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Lovell</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Bromidge</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Characterization of SB-269970-a, a selective 5-HT(7) receptor antagonist</article-title>
<source/>Br J Pharmacol
          <year>2000</year>
<volume>130</volume>
<fpage>539</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0703357</pub-id>
<pub-id pub-id-type="pmid">10821781</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harfstrand</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fuxe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cintra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Agnati</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Zini</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wikstrom</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Okret</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Steinbusch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Verhofstad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1986</year>
<volume>83</volume>
<fpage>9779</fpage>
<lpage>9783</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.83.24.9779</pub-id>
<pub-id pub-id-type="pmid">2879285</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>1996</year>
<volume>20</volume>
<fpage>147</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/0278-5846(95)00299-5</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Azmitia</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Structure and function of the brain serotonin system</article-title>
<source/>Physiol Rev
          <year>1992</year>
<volume>72</volume>
<fpage>165</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.1992.72.1.165</pub-id>
<pub-id pub-id-type="pmid">1731370</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Judge</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Gartside</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>GABA receptor modulation of 5-HT neuronal firing: characterization and effect of moderate in vivo variations in glucocorticoid levels</article-title>
<source/>Neurochem Int
          <year>2004</year>
<volume>45</volume>
<fpage>1057</fpage>
<lpage>1065</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2004.05.003</pub-id>
<pub-id pub-id-type="pmid">15337305</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Köhler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cierpinsky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kronenberg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Adli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The serotonergic system in the neurobiology of depression: relevance for novel antidepressants</article-title>
<source/>J Psychopharmacol
          <year>2016</year>
<volume>30</volume>
<fpage>13</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1177/0269881115609072</pub-id>
<pub-id pub-id-type="pmid">26464458</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sowa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kamińska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gołembiowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>5-HT<sub>7</sub> receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>324</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00324</pub-id>
<pub-id pub-id-type="pmid">26347612</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laaris</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Haj-Dahmane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lanfumey</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT<sub>1A</sub> autoreceptor functioning in the rat dorsal raphe nucleus</article-title>
<source/>Neuropharmacology
          <year>1995</year>
<volume>34</volume>
<fpage>1201</fpage>
<lpage>1210</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3908(95)00095-N</pub-id>
<pub-id pub-id-type="pmid">8532191</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Corre</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy</article-title>
<source/>Psychopharmacology
          <year>1997</year>
<volume>130</volume>
<fpage>368</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1007/s002130050252</pub-id>
<pub-id pub-id-type="pmid">9160853</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Valentino</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Waterhouse</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Glutamatergic afferent projections to the dorsal raphe nucleus of the rat</article-title>
<source/>Brain Res
          <year>2003</year>
<volume>963</volume>
<fpage>57</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(02)03841-6</pub-id>
<pub-id pub-id-type="pmid">12560111</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leitch</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>McQuade</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gartside</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression</article-title>
<source/>Neuropsychopharmacology
          <year>2003</year>
<volume>28</volume>
<fpage>119</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300016</pub-id>
<pub-id pub-id-type="pmid">12496947</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jolas</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aghajanian</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus</article-title>
<source/>Brain Res
          <year>2000</year>
<volume>873</volume>
<fpage>34</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(00)02468-9</pub-id>
<pub-id pub-id-type="pmid">10915808</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luine</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Effects of chronic corticosterone ingestion on spatial memory performance and hippocampal serotonergic function</article-title>
<source/>Brain Res
          <year>1993</year>
<volume>616</volume>
<fpage>65</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(93)90193-Q</pub-id>
<pub-id pub-id-type="pmid">7689414</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahar</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bambico</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nobrega</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects</article-title>
<source/>Neurosci Biobehav Rev
          <year>2014</year>
<volume>38</volume>
<fpage>173</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.11.009</pub-id>
<pub-id pub-id-type="pmid">24300695</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDevitt</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Neumaier</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective</article-title>
<source/>J Chem Neuroanat
          <year>2011</year>
<volume>41</volume>
<fpage>234</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1016/j.jchemneu.2011.05.001</pub-id>
<pub-id pub-id-type="pmid">21620956</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mnie-Filali</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lambás-Señas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>El Mansari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Belblidia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gondard</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Etiévant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scarna</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Didier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berod</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haddjeri</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Pharmacological blockade of 5-HT<sub>7</sub> receptors as a putative fast acting antidepressant strategy</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<fpage>1275</fpage>
<lpage>1288</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2011.13</pub-id>
<pub-id pub-id-type="pmid">21326194</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monti</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Leopoldo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jantos</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat</article-title>
<source/>Behav Brain Res
          <year>2008</year>
<volume>191</volume>
<fpage>184</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2008.03.025</pub-id>
<pub-id pub-id-type="pmid">18466985</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikiforuk</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Targeting the serotonin 5-HT7 receptor in the search for treatments for CNS disorders: rationale and Progress to date</article-title>
<source/>CNS Drugs
          <year>2015</year>
<volume>29</volume>
<fpage>265</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1007/s40263-015-0236-0</pub-id>
<pub-id pub-id-type="pmid">25721336</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Neuroendocrine aspects of hypercortisolism in major depression</article-title>
<source/>Horm Behav
          <year>2003</year>
<volume>43</volume>
<fpage>60</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/S0018-506X(02)00016-8</pub-id>
<pub-id pub-id-type="pmid">12614635</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rainer</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Quesseveur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gardier</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>David</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Guiard</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration</article-title>
<source/>Mol Pharmacol
          <year>2012</year>
<volume>81</volume>
<fpage>106</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1124/mol.111.075796</pub-id>
<pub-id pub-id-type="pmid">22031471</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Grillo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Piroli</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>The As and Ds of stress: metabolic, morphological and behavioral consequences</article-title>
<source/>Eur J Pharmacol
          <year>2008</year>
<volume>585</volume>
<fpage>64</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2008.02.050</pub-id>
<pub-id pub-id-type="pmid">18387603</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Bate</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Kew</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>GABAergic modulation of 5-HT<sub>7</sub> receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus</article-title>
<source/>Neuropharmacology
          <year>2004</year>
<volume>46</volume>
<fpage>935</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.01.010</pub-id>
<pub-id pub-id-type="pmid">15081790</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozeske</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Lowry</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>Uncontrollable, but not controllable, stress desensitizes 5-HT<sub>1</sub> receptors in the dorsal raphe nucleus</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<fpage>14107</fpage>
<lpage>14115</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.3095-11.2011</pub-id>
<pub-id pub-id-type="pmid">21976495</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zensho</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamawaki</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes</article-title>
<source/>Brain Res
          <year>1998</year>
<volume>784</volume>
<fpage>57</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(97)01185-2</pub-id>
<pub-id pub-id-type="pmid">9518551</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soiza-Reilly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Commons</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Unraveling the architecture of the dorsal raphe synaptic neuropil using high-resolution neuroanatomy</article-title>
<source/>Front Neural Circuits
          <year>2014</year>
<volume>8</volume>
<fpage>105</fpage>
<pub-id pub-id-type="doi">10.3389/fncir.2014.00105</pub-id>
<pub-id pub-id-type="pmid">25206323</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stahl</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects</article-title>
<source/>J Affect Disord
          <year>1998</year>
<volume>51</volume>
<fpage>215</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0327(98)00221-3</pub-id>
<pub-id pub-id-type="pmid">10333979</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterner</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Kalynchuk</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>2010</year>
<volume>34</volume>
<fpage>777</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.03.005</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrón</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders</article-title>
<source/>Rev Neurosci
          <year>2014</year>
<volume>25</volume>
<fpage>439</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1515/revneuro-2014-0017</pub-id>
<pub-id pub-id-type="pmid">24663228</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zahorodna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bobula</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>5-HT<sub>7</sub> receptors increase the excitability of rat hippocampal CA1 pyramidal neurons</article-title>
<source/>Brain Res
          <year>2003</year>
<volume>993</volume>
<fpage>230</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2003.09.015</pub-id>
<pub-id pub-id-type="pmid">14642852</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pitra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Duszynska</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT(7) receptors in rat hippocampus</article-title>
<source/>J Physiol Pharmacol
          <year>2009</year>
<volume>60</volume>
<fpage>83</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">19617650</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bobula</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kusek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The 5-HT(7) receptor antagonist SB 269970 counteracts restraint stress-induced attenuation of long-term potentiation in rat frontal cortex</article-title>
<source/>J Physiol Pharmacol
          <year>2011</year>
<volume>62</volume>
<fpage>663</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="pmid">22314569</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bobula</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Grzegorzewska-Hiczwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kusek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Stress- and antidepressant treatment-induced modifications of 5-HT<sub>7</sub> receptor functions in the rat brain</article-title>
<source/>Pharmacol Rep
          <year>2012</year>
<volume>64</volume>
<fpage>1305</fpage>
<lpage>1315</lpage>
<pub-id pub-id-type="doi">10.1016/S1734-1140(12)70928-3</pub-id>
<pub-id pub-id-type="pmid">23406741</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokarski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zelek-Molik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Duszyńska</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Satała</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bobula</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kusek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chmielarz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nalepa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Acute and repeated treatment with the 5-HT<sub>7</sub> receptor antagonist SB 269970 induces functional desensitization of 5-HT<sub>7</sub> receptors in rat hippocampus</article-title>
<source/>Pharmacol Rep
          <year>2012</year>
<volume>64</volume>
<fpage>256</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1016/S1734-1140(12)70763-6</pub-id>
<pub-id pub-id-type="pmid">22661174</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasefi</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kruk</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Heikkila</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Beazely</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFβ receptor dependent</article-title>
<source/>J Neurochem
          <year>2013</year>
<volume>125</volume>
<fpage>26</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12157</pub-id>
<pub-id pub-id-type="pmid">23336565</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zahorodna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Imipramine and citalopram reverse corticosterone-induced alterations in the effects of the activation of 5-HT(1A) and 5-HT(2) receptors in rat frontal cortex</article-title>
<source/>J Physiol Pharmacol
          <year>2006</year>
<volume>57</volume>
<fpage>389</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="pmid">17033092</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A mouse model of depression induced by repeated corticosterone injections</article-title>
<source/>Eur J Pharmacol
          <year>2008</year>
<volume>581</volume>
<fpage>113</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2007.12.005</pub-id>
<pub-id pub-id-type="pmid">18184609</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>